1. Home
  2. GNFT vs GRAF Comparison

GNFT vs GRAF Comparison

Compare GNFT & GRAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • GRAF
  • Stock Information
  • Founded
  • GNFT 1999
  • GRAF 2021
  • Country
  • GNFT France
  • GRAF United States
  • Employees
  • GNFT N/A
  • GRAF N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • GRAF
  • Sector
  • GNFT Health Care
  • GRAF
  • Exchange
  • GNFT Nasdaq
  • GRAF NYSE
  • Market Cap
  • GNFT 296.4M
  • GRAF 288.9M
  • IPO Year
  • GNFT 2019
  • GRAF 2024
  • Fundamental
  • Price
  • GNFT $4.00
  • GRAF $10.09
  • Analyst Decision
  • GNFT Strong Buy
  • GRAF
  • Analyst Count
  • GNFT 1
  • GRAF 0
  • Target Price
  • GNFT $13.00
  • GRAF N/A
  • AVG Volume (30 Days)
  • GNFT 7.9K
  • GRAF 40.5K
  • Earning Date
  • GNFT 09-19-2024
  • GRAF 01-01-0001
  • Dividend Yield
  • GNFT N/A
  • GRAF N/A
  • EPS Growth
  • GNFT N/A
  • GRAF N/A
  • EPS
  • GNFT 0.47
  • GRAF 0.25
  • Revenue
  • GNFT $86,225,222.00
  • GRAF N/A
  • Revenue This Year
  • GNFT $155.44
  • GRAF N/A
  • Revenue Next Year
  • GNFT N/A
  • GRAF N/A
  • P/E Ratio
  • GNFT $8.13
  • GRAF $40.59
  • Revenue Growth
  • GNFT 175.45
  • GRAF N/A
  • 52 Week Low
  • GNFT $3.31
  • GRAF $9.03
  • 52 Week High
  • GNFT $6.42
  • GRAF $11.02
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 30.28
  • GRAF N/A
  • Support Level
  • GNFT $3.89
  • GRAF N/A
  • Resistance Level
  • GNFT $4.24
  • GRAF N/A
  • Average True Range (ATR)
  • GNFT 0.11
  • GRAF 0.00
  • MACD
  • GNFT -0.01
  • GRAF 0.00
  • Stochastic Oscillator
  • GNFT 21.01
  • GRAF 0.00

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About GRAF GRAF GLOBAL CORP

Graf Global Corp is a blank check company.

Share on Social Networks: